Literature DB >> 15297530

High prevalence of Helicobacter Species detected in laboratory mouse strains by multiplex PCR-denaturing gradient gel electrophoresis and pyrosequencing.

Hans-Olof Nilsson1, Ibn-Sina Ouis, Unne Stenram, Asa Ljungh, Anthony P Moran, Torkel Wadström, Waleed Abu Al-Soud.   

Abstract

Rodent models have been developed to study the pathogenesis of diseases caused by Helicobacter pylori, as well as by other gastric and intestinal Helicobacter spp., but some murine enteric Helicobacter spp. cause hepatobiliary and intestinal tract diseases in specific inbred strains of laboratory mice. To identify these murine Helicobacter spp., we developed an assay based on PCR-denaturing gradient gel electrophoresis and pyrosequencing. Nine strains of mice, maintained in four conventional laboratory animal houses, were assessed for Helicobacter sp. carriage. Tissue samples from the liver, stomach, and small intestine, as well as feces and blood, were collected; and all specimens (n = 210) were screened by a Helicobacter genus-specific PCR. Positive samples were identified to the species level by multiplex denaturing gradient gel electrophoresis, pyrosequencing, and a H. ganmani-specific PCR assay. Histologic examination of 30 tissue samples from 18 animals was performed. All mice of eight of the nine strains tested were Helicobacter genus positive; H. bilis, H. hepaticus, H. typhlonius, H. ganmani, H. rodentium, and a Helicobacter sp. flexispira-like organism were identified. Helicobacter DNA was common in fecal (86%) and gastric tissue (55%) specimens, whereas samples of liver tissue (21%), small intestine tissue (17%), and blood (14%) were less commonly positive. Several mouse strains were colonized with more than one Helicobacter spp. Most tissue specimens analyzed showed no signs of inflammation; however, in one strain of mice, hepatitis was diagnosed in livers positive for H. hepaticus, and in another strain, gastric colonization by H. typhlonius was associated with gastritis. The diagnostic setup developed was efficient at identifying most murine Helicobacter spp.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297530      PMCID: PMC497606          DOI: 10.1128/JCM.42.8.3781-3788.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Monitoring sentinel mice for Helicobacter hepaticus, H rodentium, and H bilis infection by use of polymerase chain reaction analysis and serologic testing.

Authors:  M T Whary; J H Cline; A E King; K M Hewes; D Chojnacky; A Salvarrey; J G Fox
Journal:  Comp Med       Date:  2000-08       Impact factor: 0.982

2.  Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions.

Authors:  H Monstein; S Nikpour-Badr; J Jonasson
Journal:  FEMS Microbiol Lett       Date:  2001-05-15       Impact factor: 2.742

3.  Intraspecific variation in small-subunit rRNA sequences in GenBank: why single sequences may not adequately represent prokaryotic taxa.

Authors:  R A Clayton; G Sutton; P S Hinkle; C Bult; C Fields
Journal:  Int J Syst Bacteriol       Date:  1995-07

4.  Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species.

Authors:  C L Franklin; L K Riley; R S Livingston; C S Beckwith; R R Hook; C L Besch-Williford; R Hunziker; P L Gorelick
Journal:  Lab Anim Sci       Date:  1999-10

5.  Identification of enterohepatic Helicobacter species by restriction fragment-length polymorphism analysis of the 16S rRNA gene.

Authors:  Z Shen; Y Feng; J G Fox
Journal:  Helicobacter       Date:  2000-09       Impact factor: 5.753

6.  Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Authors:  A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

9.  Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay.

Authors:  B Shames; J G Fox; F Dewhirst; L Yan; Z Shen; N S Taylor
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice.

Authors:  J G Fox; L L Yan; F E Dewhirst; B J Paster; B Shames; J C Murphy; A Hayward; J C Belcher; E N Mendes
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more
  12 in total

1.  Differential detection of five mouse-infecting helicobacter species by multiplex PCR.

Authors:  Sunlian Feng; Karin Ku; Emir Hodzic; Edward Lorenzana; Kim Freet; Stephen W Barthold
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

2.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

3.  Interferon-γ inhibits ghrelin expression and secretion via a somatostatin-mediated mechanism.

Authors:  Jesper A B Strickertsson; Kristina B V Døssing; Anna J M Aabakke; Hans-Olof Nilsson; Thomas V O Hansen; Ulrich Knigge; Andreas Kjær; Torkel Wadström; Lennart Friis-Hansen
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

4.  PCR and RT-PCR in the Diagnosis of Laboratory Animal Infections and in Health Monitoring.

Authors:  Susan R Compton
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-24       Impact factor: 1.232

5.  Morphologic, genetic, and biochemical characterization of Helicobacter magdeburgensis, a novel species isolated from the intestine of laboratory mice.

Authors:  Francisco Rivas Traverso; Ulrich R M Bohr; Omar A Oyarzabal; Manfred Rohde; Alexandra Clarici; Thomas Wex; Doerthe Kuester; Peter Malfertheiner; James G Fox; Steffen Backert
Journal:  Helicobacter       Date:  2010-10       Impact factor: 5.753

6.  miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.

Authors:  Tony Bou Kheir; Ewa Futoma-Kazmierczak; Anders Jacobsen; Anders Krogh; Linda Bardram; Christoffer Hother; Kirsten Grønbæk; Birgitte Federspiel; Anders H Lund; Lennart Friis-Hansen
Journal:  Mol Cancer       Date:  2011-03-18       Impact factor: 27.401

7.  High prevalence and species diversity of Helicobacter spp. detected in wild house mice.

Authors:  Dagmar Čížková; Josef Bryja; Jana Albrechtová; Heidi C Hauffe; Jaroslav Piálek
Journal:  Appl Environ Microbiol       Date:  2012-09-07       Impact factor: 4.792

8.  Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility.

Authors:  U R M Bohr; M Selgrad; C Ochmann; S Backert; W König; A Fenske; T Wex; P Malfertheiner
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America.

Authors:  Nancy S Taylor; Shilu Xu; Prashant Nambiar; Floyd E Dewhirst; James G Fox
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

Review 10.  Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases.

Authors:  Trenton R Schoeb; Daniel C Bullard
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.